| Identification | Back Directory | [Name]
1H-Isoindole-1,3(2H)-dione, 5-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)- | [CAS]
2357113-68-7 | [Synonyms]
5-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione,
1H-Isoindole-1,3(2H)-dione, 5-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-1-piperazinyl]-2-(2,6-dioxo-3-piperidinyl)- | [Molecular Formula]
C25H35N5O7 | [MDL Number]
MFCD34473299 | [MOL File]
2357113-68-7.mol | [Molecular Weight]
517.57 |
| Hazard Information | Back Directory | [Biological Activity]
Thalidomide-Piperazine-PEG3-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. | [References]
[1]. Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine. Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1001. |
|
|